Study yields unexpected results from empagliflozin after heart attack
A new study, authored by KBH Professor Jan Inge Henter and published in the New England Journal of Medicine, has investigated ...
Healio14h
Semaglutide may raise risk for form of optic neuropathy in adults with type 2 diabetes
Adults with type 2 diabetes may have a higher risk for developing nonarteritic anterior ischemic optic neuropathy while using ...
Ozempic really could blind you, major study of 37million concludes
American doctors, who tracked over 37 million people, said the injections put users at higher risk of nonarteritic ischemic ...
Armed robbery in Revesby19h
Empagliflozin Post-Heart Attack: Study Reveals Surprise
A new study, authored by KBH Professor Jan Inge Henter and published in the New England Journal of Medicine, has investigated ...
Medpage Today on MSN1d
Semaglutide Tied to Small Risk of Potentially Blinding Eye Condition
The use of semaglutide (Ozempic) was tied to a small risk of nonarteritic anterior ischemic optic neuropathy (NAION) in ...
Medical News Today1d
Drug for diabetes and kidney disease may also lower heart attack, stroke risks
An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...
thecardiologyadvisor.com6d
Empagliflozin, Dapagliflozin Comparably Reduce AKI, CKD Risks in Diabetes Population
Observational data fill a knowledge gap in the absence of randomized trials comparing empagliflozin vs dapagliflozin in patients with type 2 diabetes.